Article info
PDFPrevention
Systematic review with meta-analysis
Among statin-treated patients, LDL, non-HDL and apoB cholesterol biomarkers were associated with increased risks of cardiovascular events
- Correspondence to: Allan David Sniderman
, Department of Medicine/Cardiology, McGill University, Royal Victoria Hospital, 687 Pine Avenue West, Room H7.22, Montreal, Quebec, Canada H3A 1A1; allansniderman{at}hotmail.com
Citation
Among statin-treated patients, LDL, non-HDL and apoB cholesterol biomarkers were associated with increased risks of cardiovascular events
Publication history
- First published August 14, 2012.
Online issue publication
July 21, 2021
Article Versions
- Previous version (21 July 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions